FY23 Corporate Strategy and Sustainability Journey
Recognition for our work
Strong ESG positioning
Featured in the top 10 global pharma companies scoring 74/100
in the 2022 S&P Global's CSA (21 Oct 2023) and Sustainability
Yearbook 2023 for the 3rd year in a row
Our 7th consecutive year inclusion in the Dow Jones Sustainability
Index in the Emerging Markets category
Scored an A- on CDP's Climate Change, a B on CDP's Water
Security, and A- on CDP's Supplier Engagement rating in 2022
Rated 'STRONG' in CRISIL's Sustainability Yearbook 2022
■
Building on governance
Won the Gold Shield in our category from the Institute of Chartered
Accountants of India (ICAI) for Excellence in Financial Reporting for
2021-22.
Won Risk Management Team of the Year Award at CRO
Leadership Summit and Awards 2022
Recognized as Company of the Year- America at the prestigious
Global Generics and Biosimilars Awards 2022
Won the Cloud Innovation of the Year award at the NASSCOM
Cloud Summit for our digital health subsidiary, SVAAS Wellness
Investing in our people
Recognized for the 6th year in a row in the Bloomberg Gender-
Equality Index, featuring as the only Indian pharma company.
Named among the top 20 employers in pharma/biotech globally
by the Science
Won the Candidate Experience Award 2022 in the United States
for the 4th time in a row
Reducing our environmental impact
▪ Named among Asia-Pacific Climate Leaders 2023 by Financial
Times (London) and Statista
■ Recognized as an Advanced Fourth Industrial Revolution Lighthouse,
part of the Global Lighthouse Network by World Economic Forum
■ Won the IGBC Green Champion Award 2022 in the category
'Pioneer in large scale adoption of green factory buildings in India'View entire presentation